This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gessner, T. Articles by Baker, R. M. Search for Related Content PubMed PubMed Citation Articles by Gessner, T. Articles by Baker, R. M.

Elevated Pentose Cycle and Glucuronyltransferase in Daunorubicin-resistant P388 Cells¹

Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263

Anthracycline resistance of P388 daunorubicin-resistant cells cannot be accounted for merely by differences in drug uptake and retention; protection against intracellular drug was also indicated.

Cytotoxicity of daunorubicin may be partially due to the formation of free radicals and reactive oxygen species (hydrogen peroxide, hydroxyl radical, singlet oxygen, and superoxide anion radical). Protection against free radicals and peroxides is largely dependent upon the availability of reduced glutathione, which in turn requires NADPH for its continual regeneration. Pentose phosphate cycle (also called hexose monophosphate shunt) is known to provide NADPH for maintenance of glutathione. Activities of the two NADPH-producing dehydrogenases of the cycle, glucose-6-phosphate and 6-phosphogluconate dehydrogenase, were 40% higher (P < 0.05) and activity of the cycle in intact cells was 2-fold higher in the resistant than the sensitive cells. The cycle was as active in these cells as it is known to be in macrophages, indicating a very effective protection against oxidative stress, free radicals, and alkylating electrophiles. Elevated activity of the pentose phosphate pathway in drug-resistant cells can represent a mechanism of resistance against multiple structurally unrelated drugs.

Efflux of daunorubicin may be aided by further metabolism to glucuronides. Daunorubicinol, a known active metabolite of daunorubicin, can be metabolized to a glucuronide by the cells and eliminated into the surrounding medium. Glucuronidation of daunorubicinol was evidenced by (a) release of daunorubicinol following glucuronidase hydrolysis of media from cell incubations with 1.8 µM daunorubicin and (b) production of radioactive glucuronide when cell homogenates were incubated with UDP-[¹⁴C]glucuronic acid plus daunorubicinol. Glucuronyltransferase activity with a broad substrate specificity was found in the cells. Using model substrates, 1-naphthol and o-aminophenol, it was determined that glucuronyltransferase activity was 4 times higher in daunorubicin-resistant than -sensitive P388 cells. Elevated glucuronyltransferase could contribute to daunorubicin and multidrug resistance.

¹ This work was supported by USPHS Grants CA21071 and CA24538 from the National Cancer Institute, and BRSG SO7-RR05648-22 from Biomedical Research Grant Program, Division of Research Resources, NIH.

² To whom requests for reprints should be addressed, at Grace Cancer Drug Center, Roswell Park Cancer Institute, 666 Elm Street, Buffalo, NY 14263.

Received 1/ 3/89. Revised 3/ 8/90.

This article has been cited by other articles:

				N. UEDA, S. M. R. CAMARGO, X. HONG, A. G. BASNAKIAN, P. D. WALKER, and S. V. SHAH Role of Ceramide Synthase in Oxidant Injury to Renal Tubular Epithelial Cells J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2384 - 2391. [Abstract] [Full Text] [PDF]

				M. Brangi, T. Litman, M. Ciotti, K. Nishiyama, G. Kohlhagen, C. Takimoto, R. Robey, Y. Pommier, T. Fojo, and S. E. Bates Camptothecin Resistance: Role of the ATP-binding Cassette (ABC), Mitoxantrone-resistance Half-Transporter (MXR), and Potential for Glucuronidation in MXR-expressing Cells Cancer Res., December 1, 1999; 59(23): 5938 - 5946. [Abstract] [Full Text] [PDF]

				P. A. Münzel, S. Schmohl, H. Heel, K. Kälberer, B. S. Bock-Hennig, and K. W. Bock Induction of Human UDP Glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Caco-2 Cells Drug Metab. Dispos., May 1, 1999; 27(5): 569 - 573. [Abstract] [Full Text]